Cargando…
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
AIM: To determine the effects of Lactobacillus acidophilus NCFM on irritable bowel syndrome (IBS) symptoms and quality of life (QoL). METHODS: In this randomized triple-blind trial, adult IBS volunteers who were recruited according to Rome III criteria received 10(9) or 10(10) colony-forming units o...
Autores principales: | Lyra, Anna, Hillilä, Markku, Huttunen, Teppo, Männikkö, Sofia, Taalikka, Mikko, Tennilä, Julia, Tarpila, Anneli, Lahtinen, Sampo, Ouwehand, Arthur C, Veijola, Lea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192275/ https://www.ncbi.nlm.nih.gov/pubmed/28082816 http://dx.doi.org/10.3748/wjg.v22.i48.10631 |
Ejemplares similares
-
Low-FODMAP vs regular rye bread in irritable bowel syndrome: Randomized SmartPill(®) study
por: Pirkola, Laura, et al.
Publicado: (2018) -
Randomised clinical trial: low‐FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome
por: Laatikainen, R., et al.
Publicado: (2016) -
Probiotic viability – does it matter?
por: Lahtinen, Sampo J.
Publicado: (2012) -
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats
por: Lyra, Anna, et al.
Publicado: (2012) -
Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
por: Hamatani, Tatsuto, et al.
Publicado: (2020)